Lasers in Medical Science

, Volume 29, Issue 1, pp 221–223 | Cite as

In vitro cell tests of pancreatic malignant tumor cells by photothermotherapy based on DMSO porous silicon colloids

  • Chanseok Hong
  • Chongmu LeeEmail author
Original Article


Dimethyl sulfoxide porous silicon (DMSO-PSi) colloid in which DMSO was used as a surfactant suitable for inhibiting the agglomeration of PSi nanoparticles was prepared for use in cancer photothermotherapy. The photothermal effect of the DMSO-PSi colloid was found to be high enough to destroy cancer cells (T = ∼52 °C). The mean particle size of the PSi nanoparticles in the DMSO-PSi colloid was 67 nm, which is low enough to flow through blood vessels without causing a blockage. The DMSO-PSi colloid in combination with an NIR laser resulted in a cell viability of 5.70 %, which is a sufficiently high cytotoxic effect.


Porous silicon nanoparticles Photothermotherapy Near-infrared light Surfactant 



This study was supported by the Korea Science and Engineering Foundation through “the 2010 Core Research Program.”


  1. 1.
    Hirsch LR, Stafford RL, Baukson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL (2003) Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 100(23):13549–13554PubMedCrossRefGoogle Scholar
  2. 2.
    Huang X, Jain PK, El-Sayed IH, El-Sayed MA (2008) Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 23:217–228PubMedCrossRefGoogle Scholar
  3. 3.
    Loo C, Lin A, Hirsch L, Lee MH, Barton J, Halas N, West J, Drezek R (2004) Nanoshell-enabled photonics-based imaging and therapy of cancer. Technol Cancer Res Treat 3(1):33–40PubMedGoogle Scholar
  4. 4.
    Kam NWS, O`Connell M, Wisdom JA, Dai H (2005) Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA 102:11600–11605PubMedCrossRefGoogle Scholar
  5. 5.
    Lee C, Kim H, Cho Y, Lee WI (2007) The properties of porous silicon as a therapeutic agent via the new photodynamic therapy. J Mater Chem 17:2648–2653CrossRefGoogle Scholar
  6. 6.
    Lee C, Hong C, Kim H, Kang J, Zheng HM (2010) TiO2 nanotubes as a therapeutic agent for cancer thermotherapy. Potochem Phobiol 86:981–989CrossRefGoogle Scholar
  7. 7.
    Lee C, Kim H, Hong C, Kim M, Hong SS, Lee DH, Lee WI (2008) Porous silicon as an agent for cancer thermotherapy based on near-infrared light irradiation. J Mater Chem 18:4790–4795CrossRefGoogle Scholar
  8. 8.
    Canham LT (1995) Bioactive silicon structure fabrication through nanoetching techniques. Adv Mater 7:1033–1037CrossRefGoogle Scholar
  9. 9.
    Anderson SHC, Elliot H, Wallis DJ, Canham LT, Powell JJ (2003) Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions. Phys Stat Soli (a) 197:331–335CrossRefGoogle Scholar
  10. 10.
    Hong C, Lee J, Son M, Hong SS, Lee C (2011) In-vivo cancer cell destruction using porous silicon nanoparticles. Anti-Cancer Drugs 22:971–977PubMedGoogle Scholar
  11. 11.
    Goldberg SN, Gazelle GS, Mueller PR (2000) Thermal ablation therapy for focal malignancy. Am J Roentgenol 174:323–331CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Department of Materials Science and EngineeringInha UniversityIncheonRepublic of Korea

Personalised recommendations